Institutional investors purchased a net $2.5 million shares of CYTR during the quarter ended December 2016. This may signal that the smart money is gaining interest in this company as the 20.69% of shares outstanding that institutional investors hold is actually below the Pharmaceuticals: Other industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
WEALTHPLAN PARTNERS, INC. Sold 2.9 Thousand shares of CytRx Corp
NATIONWIDE FUND ADVISORS Sold 24.0 Thousand shares of CytRx Corp
SIMPLEX TRADING LLC Sold 26.4 Thousand shares of CytRx Corp